International Journal of Physiotherapy Research and Clinical Practice
DOI: 10.54839/ijprcp.v3i2.shakambari
Year: 2024, Volume: 3, Issue: 2, Pages: 21–24
Original Article
Shakambari1, Raja1, Samuel Paul Isaac1
1Krupanidhi College of Physiotherapy, Bangalore, Karnataka, India
A frequent ailment that usually affects people between the ages of 40 and 60, adhesive Capsulitis is marked by pain and limited shoulder movement. Physiotherapy, including joint mobilization techniques, is often used to alleviate symptoms. This study aimed to compare the effectiveness of two manual therapeutic techniques—Mulligan’s Mobilization with Movement (MWM) and Kaltenborn’s posterior mobilization— in helping Adhesive Capsulitis patients with shoulder function and pain reduction. The study was quasi-experimentalwith 40 participants (aged 35-70 years) diagnosed with adhesive capsulitis. Participants were randomly assigned to two groups: Mulligan's MWM was given to Group B, whereas Kaltenborn's posterior mobilization was given to Group Aboth combined with ultrasound therapy and conventional treatments over 3 weeks. The Visual Analog Scale (VAS) and the Shoulder Pain and impairment Index (SPADI) were used to quantify pain and impairment before and after treatment. Both techniques resulted in significant reduction in pain and disability (p < 0.001). However, Group B (Mulligan’s MWM) showed more pronounced improvements, with greater reductions in both VAS and SPADI scores than Group A (Kaltenborn’s mobilization), suggesting a more effective treatment approach. This study provides a direct comparison between Mulligan’s MWM and Kaltenborn’s posterior mobilization for managing adhesive capsulitis, highlighting the superior effectivenessof Mulligan’s technique in improving pain relief and functional outcomes.
Keywords: Adhesive capsulitis, Mulligan's Mobilization with Movement, Kaltenborn's mobilization, Shoulder pain, Disability
@ 2024 Published by Krupanidhi College of Physiotherapy. This is an open-access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/)
Subscribe now for latest articles and news.